HOMEVULNERABILITIESCVE-2026-33869
MEDIUM

CVE-2026-33869

CWE-863Published: March 27, 2026· Updated: Mar 30, 2026

4.8
CVSS v3.1
EPSS:0.04%probability of exploitation in 30 daysPercentile:12.1th

Official Description

Mastodon is a free, open-source social network server based on ActivityPub. In versions on the 4.5.x branch prior to 4.5.8 and on the 4.4.x branch prior to 4.4.15, an attacker that knows of a quote before it has reached a server can prevent it from being correctly processed on that server. The vulnerability has been patched in Mastodon 4.5.8 and 4.4.15. Mastodon 4.3 and earlier are not affected because they do not support quotes.

NVD Source

Technical Analysis

CVE-2026-33869 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityHigh
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityNone
IntegrityLow
AvailabilityLow
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:L/A:L

Affected Vendors & Products

joinmastodon1 product
mastodon
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (1)

Quick Facts

CVE IDCVE-2026-33869
CVSS Score4.8 / 10
SeverityMEDIUM
WeaknessCWE-863
CISA KEVNo
EPSS (30d)0.04%
Affected1 vendor
PublishedMar 27, 2026

Related CVEs (CWE-863)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2026-33869 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.